TL;DR

Ruminococcus gnavus uses mucin glycans in a strain-dependent manner: ATCC 29149 (and related mucin-degraders) grow with mucin as sole carbon source and express dedicated glycoside hydrolases and a sialic acid catabolic nan cluster. Enzymatic, transcriptomic, mutant and in vivo colonization data support mucin foraging by R. gnavus.

Growth assays show strain dependent mucin use

R. gnavus growth experiments directly tested mucin as a sole carbon source and demonstrated clear strain differences, which answers whether the species can grow on intact mucins. Several studies performed in vitro mono-culture growth assays and co-culture fermentations, measuring bacterial abundance, transcripts, and metabolites to show that some R. gnavus strains use mucin for growth.

  • Key finding: Only certain strains (notably ATCC 29149) grew when porcine/human mucin was supplied as the sole carbon source, whereas other strains (e.g., E1) could assimilate mucin monosaccharides but did not grow on intact mucin in the same conditions [1].
  • Methods summary: Growth was assayed in defined/minimal media with mucin as the only carbohydrate source; growth readouts included optical density and colony counts or molecular quantification methods in later studies [1] [2].
  • Co-culture assays: In anaerobic fermentations comparing growth on mucin or starch, R. gnavus ATCC 29149 showed mucin-dependent growth and produced fermentation end-products, with quantitative PCR used to track populations and 1H NMR to profile metabolites [2].
  • Community-level validation: Multi-omics and defined-media screens confirmed R. gnavus among taxa able to grow in chemically defined media supplemented with intestinal mucin as sole carbon source in independent phenotyping studies [3] [4].

Enzymatic evidence for mucin glycan degradation

Biochemical and genomic studies characterized glycoside hydrolases and sialidases that release mucin terminal sugars, providing mechanistic proof that R. gnavus can depolymerize mucin glycans. Experiments combined enzyme purification, substrate panels, mass spectrometry, and transcriptomics to link specific enzymes to mucin breakdown.

  • Sialidase and trans‑sialidase activity: An intramolecular trans‑sialidase (IT‑sialidase) expressed by mucin‑degrading strains releases 2,7‑anhydro‑Neu5Ac from sialylated mucins; strains encoding this activity grow on the 2,7‑anhydro‑Neu5Ac product as sole carbon source [5].
  • Fucosidases and specificity: Purified α‑L‑fucosidases from R. gnavus displayed linkage- and glycan-specific activity against fucosylated mucin epitopes, including the ability to hydrolyze α1‑3/4 linkages on sialylated substrates without prior desialylation [6].
  • GH98 blood group endo‑β‑1,4‑galactosidase: RgGH98 from ATCC 29149 was shown by HPAEC‑PAD, LC‑FD‑MS/MS and MALDI‑ToF MS to cleave blood‑group A motifs from mucin; pretreatment of mucin with RgGH98 liberated oligosaccharides and enabled growth of a non‑mucin‑degrading strain on the exposed glycans [7].
  • Molecular evidence: Genes encoding these GHs and the nan (sialic acid catabolism) cluster were upregulated when R. gnavus was grown on mucin, as shown by RNA‑seq and RT‑qPCR, linking enzyme expression to mucin growth conditions [1] [7] [5].

Metabolic characterization and end products

Metabolic profiling and pathway dissection identified the fate of mucin-derived sugars in R. gnavus and demonstrated strain-specific catabolic routes, including a unique 2,7‑anhydro‑Neu5Ac pathway and fermentation outputs when grown on mucin.

  • Unique sialic acid pathway: R. gnavus ATCC 29149 expresses a transporter specific for 2,7‑anhydro‑Neu5Ac and an oxidoreductase plus Neu5Ac‑specific aldolase to convert and catabolize this product; deletion of the nan cluster abolished growth on sialylated substrates in vitro [8].
  • Growth on sialic acid derivatives: Mucin‑degrading strains grew on 2,7‑anhydro‑Neu5Ac as sole carbon source, demonstrating utilization of the IT‑sialidase product [5] [8].
  • Fermentation end-products: When cultured on mucin or fucosylated glycans, ATCC 29149 produced short‑chain fermentation products including acetate, propionate and propanol, indicating mucin-derived carbon is routed to typical anaerobic fermentation pathways [1] [2].
  • Analytical methods: Metabolites were quantified by 1H NMR and other chromatographic methods, while transporter/enzyme specificity was characterized by biochemical assays, ITC, NMR and crystallography for key GHs and transport proteins [8] [7] [6].

In vivo relevance and ecological interactions

Genetic and animal experiments linked mucin foraging to fitness in the gut and to cross‑feeding relationships that shape microbial communities, establishing ecological consequences of R. gnavus mucin utilization.

  • Mutant colonization defect: A nan‑cluster deletion mutant of R. gnavus (unable to metabolize 2,7‑anhydro‑Neu5Ac) lost the ability to grow on sialylated substrates in vitro and showed significantly impaired colonization of the mucus layer in gnotobiotic mouse co‑colonization experiments, demonstrating in vivo fitness reliance on mucin‑derived sialic acid [8].
  • Cross‑feeding and niche interactions: Co‑culture experiments showed R. bromii supports R. gnavus growth on starch by releasing malto‑oligosaccharides, whereas R. gnavus mucin degradation releases monosaccharides that can support growth of other gut microbes, indicating ecological cross‑feeding stemming from mucin foraging [2].
  • Transcriptomic and metabolomic context: In vivo and in vitro multi‑omics linked mucin availability to expression of GHs, transporters and metabolic pathways in R. gnavus, and to altered host–microbe metabolic interactions, underscoring the ecological role of mucin utilization [3] [8].